https://orcid.org/0000-0002-1470-7192
Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Sophia Moshegov & Nathan Mitchell Kerr. (2023) Prostaglandin FP receptor agonists in the treatment of glaucoma and ocular hypertension: a literature review. Expert Opinion on Investigational Drugs 32:11, pages 1017-1023.
Read now
Read now
Francesco Mincione, Alessio Nocentini & Claudiu T. Supuran. (2021) Advances in the discovery of novel agents for the treatment of glaucoma. Expert Opinion on Drug Discovery 16:10, pages 1209-1225.
Read now
Read now
Mehmet Cem Sabaner, Resat Duman, Ayhan Vurmaz & Tolga Ertekin. (2021) Effects of topical prostaglandin drops on angiogenesis in an in ovo chick chorioallantoic membrane model. Cutaneous and Ocular Toxicology 40:1, pages 54-60.
Read now
Read now
Claudiu T. Supuran. (2021) Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1702-1714.
Read now
Read now
Lindsay Machen, Reza Razeghinejad & Jonathan S. Myers. (2020) Fixed-combination topical anti-hypertensive ophthalmic agents. Expert Opinion on Pharmacotherapy 21:10, pages 1269-1282.
Read now
Read now
Claudiu T. Supuran. (2020) An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Expert Opinion on Drug Metabolism & Toxicology 16:4, pages 297-307.
Read now
Read now
Zhuang Hou, Chuanchao Li, Yichuang Liu, Miao Zhang, Yitong Wang, Zhanfang Fan, Chun Guo, Bin Lin & Yang Liu. (2020) Design, synthesis and biological evaluation of carbohydrate-based sulphonamide derivatives as topical antiglaucoma agents through selective inhibition of carbonic anhydrase II. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 383-390.
Read now
Read now
Claudiu T. Supuran, Abdulmalik Saleh Alfawaz Altamimi & Fabrizio Carta. (2019) Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019. Expert Opinion on Therapeutic Patents 29:10, pages 781-792.
Read now
Read now
Claudiu T Supuran. (2019) The management of glaucoma and macular degeneration. Expert Opinion on Therapeutic Patents 29:10, pages 745-747.
Read now
Read now
Articles from other publishers (13)
V. N. Fedorov, V. P. Vdovichenko, M. K. Korsakov, V. V. Strakhov, A. A. Popova, A. I. Khokhlov & S. S. Suleymanov. (2023) Pharmacotherapy of glaucoma in terms of evidence-based medicine. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice:3, pages 44-54.
Crossref
Crossref
S Subbulakshmi, Srinivasan Kavitha & Rengaraj Venkatesh. (2023) Prostaglandin analogs in ophthalmology. Indian Journal of Ophthalmology 71:5, pages 1768-1776.
Crossref
Crossref
Amirah Mohammad Razali, Seng Fai Tang, Syed Zulkifli Syed Zakaria, Jemaima Che-Hamzah, Tin Aung, Othmaliza Othman & Norshamsiah Md Din. (2023) The Effect of Combined Phacoemulsification and Endo-Cyclophotocoagulation on Intraocular Pressure Fluctuation Assessed by the Water Drinking Test in Patients with Primary Open Angle Glaucoma. Ophthalmic Research, pages 854-861.
Crossref
Crossref
Claudiu T. Supuran. 2023. Nitric Oxide in Health and Disease. Nitric Oxide in Health and Disease
305
317
.
Lin Zhou, Wenyi Zhan & Xin Wei. (2022) Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma. Frontiers in Pharmacology 13.
Crossref
Crossref
Kentaro Hanada, Shota Sakai & Keigo Kumagai. (2022) Natural Ligand-Mimetic and Nonmimetic Inhibitors of the Ceramide Transport Protein CERT. International Journal of Molecular Sciences 23:4, pages 2098.
Crossref
Crossref
Rama Mohana Reddy Jaggavarapu, Venkatanarayana Muvvala, Ventakareddy Ghojala & Ravi Kumar Cheedarala. (2022) Isolation, Characterization, and Docking Studies of (Z)-Isopropyl 7-((1R, 2R, 3R, 5S)-
2-((1E, 3Z)-3-Fluoro-4-Phenoxybuta-1, 3-Dienyl)-3,5-Dihydroxycyclopentyl) Hept-5-
Enoate, an Impurity of Tafluprost. Current Organic Synthesis 19:1, pages 10-15.
Crossref
Crossref
Jing Bao, Ze Yang, Sifan Zheng, Jingjia Li & Xingchao Shentu. (2022) Circulating fatty acids and risk of primary open-angle glaucoma: A mendelian randomization study. Gene 811, pages 146078.
Crossref
Crossref
Peiyu Liu, Feifei Wang, Yuning Song, Menghui Wang & Xu Zhang. (2022) Current situation and progress of drugs for reducing intraocular pressure. Therapeutic Advances in Chronic Disease 13, pages 204062232211403.
Crossref
Crossref
Tao Wang, Linlin Cao, Qikun Jiang & Tianhong Zhang. (2021) Topical Medication Therapy for Glaucoma and Ocular Hypertension. Frontiers in Pharmacology 12.
Crossref
Crossref
Javier F. Casiraghi, Daniel Grigera, J. Alejo Peyret, Melina del Papa & María Silvia Passerini. (2021) Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial. Re:GEN Open 1:1, pages 110-116.
Crossref
Crossref
Claudiu T. Supuran. (2021) Emerging role of carbonic anhydrase inhibitors. Clinical Science 135:10, pages 1233-1249.
Crossref
Crossref
Ke Li, Jing Zhao, Mingxuan Wang, Lingzhi Niu, Yuanping Wang, Yanxia Li & Yajuan Zheng. (2021) The Roles of Various Prostaglandins in Fibrosis: A Review. Biomolecules 11:6, pages 789.
Crossref
Crossref